Key points are not available for this paper at this time.
We evaluated the protection afforded by SARS-CoV-2 infection-induced immunity against reinfection among working age vaccinated during a calendar period from June to December 2022 when Omicron BA.5 was the dominating subvariant in Scania county, Sweden. The study cohort (n = 71 592) mainly consisted of health care workers. We analysed 4 144 infected cases during Omicron BA.5 dominance and 41 440 sex and age matched controls with conditional logistic regression. The average protection against reinfection was marginal (16%, 95% confidence interval CI 7 to 23%) during the study period, but substantially higher for recent infections. Recent infection (3–6 months) with Omicron BA.2 and BA.5 both offered strong protection (86%, 95% CI 68 to 94% and 78%, 95% CI 69 to 84%), whereas more distant infection (6–12 months) with Omicron BA.1, BA.2 and the variants before Omicron offered marginal or no protection. These findings suggest that infection-induced immunity contributes to short-term population protection against infection with the subvariant BA.5 among working age vaccinated, but wanes considerably with time independent of virus variant.
Kahn et al. (Wed,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: